Pharmaceutical company Jugohemija will today receive the first 140,000 doses of the Novartis swine flu vaccines from the Swiss company’s plant in Siena, Italy.

The vaccines will be transported by special refrigerator trucks to the Torlak Institute in Belgrade, Jugohemija has announced.